Drug May Delay High Blood Pressure Onset In Prehypertension
A large study tested candesartan in prehypertension, enrolling 772 participants with an average age of 48. Over two years the drug reduced progression to hypertension compared with placebo, but after stopping therapy in year three the incidence rose to match the control group, indicating delay not prevention.
MENTIONED IN THIS ARTICLE
Atlanta
Elizabeth Nabel
National Heart, Lung and Blood Institute
Steve Julius
University of Michigan
Ann Arbor
AstraZeneca PLC
James Stein
University of Wisconsin-Madison
American College of Cardiology
New England Journal of Medicine
Nabel
Tom Giles
American Society of Hypertension
Julius
Thomas D. Holley
R.ph
Also Mentioned on This Page
Stein
Populatio
American Heart Association
University Pkwy
Aiken
University
Algo Comun
Visa
MasterCard
Discover
Affordable Dentures
Augusta
P.C
Bradford R. Thompson, Dmd
Alan W. Brown, Dmd
Augusta West Parkway
Sitter Sayee
Be A
Affordabledentures.com
Aiken, Llc
Laurens Street
Gees Cee Meo
Bellsouth.net
Robbie Yarborough and
Jenny Yarborough
Bernina
Alta
Ag Re
Georgia
Sewgallery.com
First Citizens Office
FDIC
First Citizens